Olaplex (OLPX) Financials

$1.28 +0.10 (+7.98%)

As of 02:11 PM Eastern

Annual Income Statements for Olaplex

This table shows Olaplex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	20	62	244
Consolidated Net Income / (Loss)	20	62	244
Net Income / (Loss) Continuing Operations	20	62	244
Total Pre-Tax Income	27	77	305
Total Operating Income	67	108	364
Total Gross Profit	292	319	520
Total Revenue	423	458	704
Operating Revenue	423	458	704
Total Cost of Revenue	130	140	185
Operating Cost of Revenue	130	140	185
Total Operating Expenses	225	210	155
Selling, General & Admin Expense	182	169	114
Amortization Expense	44	41	41
Total Other Income / (Expense), net	-40	-32	-59
Interest Expense	60	58	63
Interest & Investment Income	25	19	2.78
Other Income / (Expense), net	-5.82	7.62	0.83
Income Tax Expense	7.39	15	61
Basic Earnings per Share	$0.03	$0.09	$0.38
Weighted Average Basic Shares Outstanding	661.98M	654.59M	649.09M
Diluted Earnings per Share	$0.03	$0.09	$0.35
Weighted Average Diluted Shares Outstanding	665.40M	677.58M	691.01M
Weighted Average Basic & Diluted Shares Outstanding	664.62M	660.76M	651.90M

This table shows Olaplex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	0.47	-8.80	15	5.78	7.75	14	20	6.16	21	34	61
Consolidated Net Income / (Loss)	0.47	-8.80	15	5.78	7.75	14	20	6.16	21	34	61
Net Income / (Loss) Continuing Operations	0.47	-8.80	15	5.78	7.75	14	20	6.16	21	34	61
Total Pre-Tax Income	0.88	-11	20	7.68	10	17	26	7.95	25	41	76
Total Operating Income	8.48	3.05	28	16	20	17	37	19	36	47	89
Total Gross Profit	67	67	82	72	71	77	84	77	81	92	130
Total Revenue	97	101	119	104	99	112	124	109	114	131	176
Operating Revenue	97	101	119	104	99	112	124	109	114	131	176
Total Cost of Revenue	30	34	37	32	28	35	40	32	33	39	47
Operating Cost of Revenue	30	34	37	32	28	35	40	32	33	39	47
Total Operating Expenses	59	64	54	56	52	60	47	59	45	45	41
Selling, General & Admin Expense	48	53	43	45	40	49	36	48	35	35	31
Amortization Expense	11	11	11	11	11	10	10	10	10	10	10
Total Other Income / (Expense), net	-7.60	-14	-8.34	-8.60	-9.25	0.09	-10	-11	-10	-5.85	-13
Interest Expense	14	15	16	15	15	15	15	15	14	13	10
Interest & Investment Income	5.95	6.31	6.61	6.26	6.20	5.80	5.18	4.47	3.38	-	-
Other Income / (Expense), net	0.18	-5.28	0.67	-0.26	-0.95	8.95	-0.97	-0.60	0.24	4.68	-2.25
Income Tax Expense	0.42	-2.00	4.86	1.90	2.62	3.15	5.89	1.80	4.30	7.58	15
Basic Earnings per Share	$0.00	($0.01)	$0.02	$0.01	$0.01	$0.02	$0.03	$0.01	$0.03	$0.05	$0.09
Weighted Average Basic Shares Outstanding	664.69M	661.98M	662.25M	661.73M	660.82M	654.59M	654.70M	654.35M	651.73M	649.09M	649.10M
Diluted Earnings per Share	$0.00	($0.01)	$0.02	$0.01	$0.01	$0.02	$0.03	$0.01	$0.03	$0.04	$0.09
Weighted Average Diluted Shares Outstanding	666.46M	665.40M	666.15M	663.55M	663.57M	677.58M	678.76M	680.35M	683.49M	691.01M	691.26M
Weighted Average Basic & Diluted Shares Outstanding	665.92M	664.62M	662.92M	661.98M	661.76M	660.76M	654.73M	654.70M	654.28M	651.90M	649.18M

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	120	144	136
Net Cash From Operating Activities	143	178	255
Net Cash From Continuing Operating Activities	143	178	255
Net Income / (Loss) Continuing Operations	20	62	244
Consolidated Net Income / (Loss)	20	62	244
Depreciation Expense	0.49	0.48	0.36
Amortization Expense	55	52	50
Non-Cash Adjustments To Reconcile Net Income	22	25	35
Changes in Operating Assets and Liabilities, net	46	38	-74
Net Cash From Investing Activities	-4.89	-3.61	-2.68
Net Cash From Continuing Investing Activities	-4.89	-3.61	-2.68
Purchase of Property, Plant & Equipment	-1.12	-0.38	-0.65
Acquisitions	-3.77	-3.24	-2.03
Net Cash From Financing Activities	-19	-30	-116
Net Cash From Continuing Financing Activities	-19	-30	-116
Repayment of Debt	-6.75	-8.44	-792
Issuance of Debt	0.00	0.00	675
Other Financing Activities, net	-12	-22	1.10
Cash Interest Paid	60	60	41
Cash Income Taxes Paid	12	7.74	60

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-5.07	47	31	0.42	41	37	51	9.08	47	73	51
Net Cash From Operating Activities	-2.92	50	33	16	44	49	53	27	48	74	54
Net Cash From Continuing Operating Activities	-2.92	50	33	16	44	49	53	27	48	74	54
Net Income / (Loss) Continuing Operations	0.47	-8.80	15	5.78	7.75	14	20	6.16	21	34	61
Consolidated Net Income / (Loss)	0.47	-8.80	15	5.78	7.75	14	20	6.16	21	34	61
Depreciation Expense	0.09	0.09	0.11	0.14	0.15	0.14	0.11	0.11	0.12	0.13	0.08
Amortization Expense	14	14	14	13	14	13	13	13	13	11	14
Non-Cash Adjustments To Reconcile Net Income	4.29	9.20	4.10	4.88	4.31	7.43	6.59	6.46	4.89	4.31	3.81
Changes in Operating Assets and Liabilities, net	-21	36	0.65	-8.04	18	14	13	1.53	9.60	24	-25
Net Cash From Investing Activities	-1.00	-1.52	-1.19	-1.09	-1.08	-0.71	-0.91	-1.37	-0.63	-0.97	-0.77
Net Cash From Continuing Investing Activities	-1.00	-1.52	-1.19	-1.09	-1.08	-0.71	-0.91	-1.37	-0.63	-0.97	-0.77
Purchase of Property, Plant & Equipment	-0.05	-0.43	-0.13	-0.11	-0.45	-0.14	-0.11	-0.02	-0.11	-0.55	-0.03
Acquisitions	-0.95	-1.09	-1.06	-0.99	-0.63	-0.58	-0.80	-1.34	-0.52	-0.42	-0.74
Net Cash From Financing Activities	-1.16	-1.00	-1.37	-15	-1.52	-12	-1.34	-17	-0.93	0.86	-1.62
Net Cash From Continuing Financing Activities	-1.16	-1.00	-1.37	-15	-1.52	-12	-1.34	-17	-0.93	0.86	-1.62
Repayment of Debt	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-3.38	0.00	-1.69
Other Financing Activities, net	0.53	0.69	0.32	-13	0.17	-9.82	0.35	-15	2.45	0.86	0.07
Cash Interest Paid	13	14	21	10	15	15	15	15	14	20	8.23
Cash Income Taxes Paid	0.62	-0.26	2.08	5.56	5.00	-1.79	0.02	9.42	0.09	5.02	20

This table presents Olaplex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,768	1,740	1,698
Total Current Assets	690	613	522
Cash & Equivalents	586	466	323
Accounts Receivable	15	41	46
Inventories, net	75	96	144
Prepaid Expenses	14	9.95	-
Plant, Property, & Equipment, net	1.44	0.93	1.03
Total Noncurrent Assets	1,077	1,126	1,174
Goodwill	168	168	168
Intangible Assets	900	948	995
Other Noncurrent Operating Assets	8.72	10	11
Total Liabilities & Shareholders' Equity	1,768	1,740	1,698
Total Liabilities	893	895	917
Total Current Liabilities	65	56	55
Short-Term Debt	6.75	6.75	8.44
Accounts Payable	10	7.07	9.75
Accrued Expenses	36	30	17
Other Current Liabilities	12	-	16
Total Noncurrent Liabilities	829	839	862
Long-Term Debt	644	649	654
Noncurrent Deferred & Payable Income Tax Liabilities	5.16	3.02	1.62
Other Noncurrent Operating Liabilities	180	187	206
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	874	845	781
Total Preferred & Common Equity	874	845	781
Preferred Stock	0.00	0.00	0.00
Total Common Equity	874	845	781
Common Stock	329	317	314
Retained Earnings	546	526	465
Accumulated Other Comprehensive Income / (Loss)	-0.77	1.37	2.58

This table presents Olaplex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,771	1,759	1,757	1,753	1,742	1,723	1,726	1,697
Total Current Assets	704	670	654	639	601	571	564	497
Cash & Equivalents	581	539	508	508	430	378	369	249
Accounts Receivable	24	35	34	26	52	50	46	93
Inventories, net	79	86	100	95	113	129	132	151
Prepaid Expenses	20	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	1.48	1.24	1.23	1.24	0.93	0.93	1.03	0.61
Total Noncurrent Assets	1,066	1,088	1,101	1,113	1,141	1,151	1,161	1,199
Goodwill	168	168	168	168	168	168	168	168
Intangible Assets	887	911	923	936	960	972	983	1,007
Other Noncurrent Operating Assets	10	8.43	9.37	8.42	12	11	10	10
Total Liabilities & Shareholders' Equity	1,771	1,759	1,757	1,753	1,742	1,723	1,726	1,697
Total Liabilities	893	879	893	898	902	905	919	953
Total Current Liabilities	66	57	71	60	56	61	58	89
Short-Term Debt	6.75	6.75	6.75	6.75	6.75	6.75	6.75	6.75
Accounts Payable	24	11	23	17	13	14	26	40
Accrued Expenses	23	20	23	18	17	25	20	26
Current Deferred & Payable Income Tax Liabilities	12	5.65	5.34	4.92	2.50	16	5.80	16
Total Noncurrent Liabilities	827	823	823	838	846	844	861	864
Long-Term Debt	642	645	646	648	650	652	653	656
Noncurrent Deferred & Payable Income Tax Liabilities	5.07	3.64	2.14	2.68	4.07	2.75	2.30	-
Other Noncurrent Operating Liabilities	180	174	174	188	191	189	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	878	880	863	856	840	818	807	744
Total Preferred & Common Equity	878	880	863	856	840	818	807	744
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	878	880	863	856	840	818	807	744
Common Stock	333	326	323	321	325	322	319	311
Retained Earnings	546	555	540	534	512	492	486	431
Accumulated Other Comprehensive Income / (Loss)	-0.75	-0.99	-0.08	1.00	2.81	3.67	2.02	1.93

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-7.77%	-34.93%	17.70%
EBITDA Growth	-30.68%	-59.62%	7.05%
EBIT Growth	-47.24%	-68.28%	8.45%
NOPAT Growth	-44.11%	-70.18%	8.85%
Net Income Growth	-68.30%	-74.77%	10.55%
EPS Growth	-66.67%	-74.29%	9.38%
Operating Cash Flow Growth	-19.41%	-30.47%	27.64%
Free Cash Flow Firm Growth	-16.98%	-64.72%	103.48%
Invested Capital Growth	-9.23%	-7.72%	-15.16%
Revenue Q/Q Growth	-2.53%	-3.98%	-4.83%
EBITDA Q/Q Growth	-19.24%	-12.53%	-10.89%
EBIT Q/Q Growth	-31.69%	-18.11%	-11.98%
NOPAT Q/Q Growth	-22.40%	-21.93%	-12.23%
Net Income Q/Q Growth	-53.98%	-24.08%	-12.75%
EPS Q/Q Growth	-50.00%	-18.18%	-12.50%
Operating Cash Flow Q/Q Growth	0.44%	-12.12%	1.52%
Free Cash Flow Firm Q/Q Growth	4.51%	-57.59%	0.00%
Invested Capital Q/Q Growth	-5.42%	-3.14%	-17.92%
Profitability Metrics	-	-	-
Gross Margin	69.15%	69.52%	73.77%
EBITDA Margin	27.55%	36.65%	59.06%
Operating Margin	15.84%	23.61%	51.74%
EBIT Margin	14.46%	25.28%	51.86%
Profit (Net Income) Margin	4.62%	13.44%	34.66%
Tax Burden Percent	72.54%	80.28%	79.96%
Interest Burden Percent	44.03%	66.23%	83.58%
Effective Tax Rate	27.46%	19.73%	20.04%
Return on Invested Capital (ROIC)	4.92%	8.06%	23.86%
ROIC Less NNEP Spread (ROIC-NNEP)	-17.95%	-1.49%	15.54%
Return on Net Nonoperating Assets (RNNOA)	-2.65%	-0.49%	13.54%
Return on Equity (ROE)	2.27%	7.58%	37.40%
Cash Return on Invested Capital (CROIC)	14.60%	16.10%	40.27%
Operating Return on Assets (OROA)	3.48%	6.74%	22.42%
Return on Assets (ROA)	1.11%	3.58%	14.98%
Return on Common Equity (ROCE)	2.27%	7.58%	37.40%
Return on Equity Simple (ROE_SIMPLE)	2.23%	7.29%	31.25%
Net Operating Profit after Tax (NOPAT)	49	87	291
NOPAT Margin	11.49%	18.96%	41.37%
Net Nonoperating Expense Percent (NNEP)	22.87%	9.55%	8.32%
Return On Investment Capital (ROIC_SIMPLE)	3.18%	5.79%	20.18%
Cost of Revenue to Revenue	30.85%	30.48%	26.23%
SG&A Expenses to Revenue	42.99%	36.86%	16.17%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	53.32%	45.91%	22.03%
Earnings before Interest and Taxes (EBIT)	61	116	365
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	116	168	416
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.31	1.97	4.33
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.71	3.63	4.80
Price to Earnings (P/E)	58.75	27.00	13.86
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	1.70%	3.70%	7.22%
Enterprise Value to Invested Capital (EV/IC)	1.29	1.79	3.32
Enterprise Value to Revenue (EV/Rev)	2.87	4.04	5.29
Enterprise Value to EBITDA (EV/EBITDA)	10.40	11.03	8.95
Enterprise Value to EBIT (EV/EBIT)	19.82	15.99	10.19
Enterprise Value to NOPAT (EV/NOPAT)	24.95	21.32	12.77
Enterprise Value to Operating Cash Flow (EV/OCF)	8.47	10.43	14.58
Enterprise Value to Free Cash Flow (EV/FCFF)	8.41	10.68	7.57
Leverage & Solvency	-	-	-
Debt to Equity	0.74	0.78	0.85
Long-Term Debt to Equity	0.74	0.77	0.84
Financial Leverage	0.15	0.33	0.87
Leverage Ratio	2.04	2.11	2.50
Compound Leverage Factor	0.90	1.40	2.09
Debt to Total Capital	42.66%	43.70%	45.91%
Short-Term Debt to Total Capital	0.44%	0.45%	0.58%
Long-Term Debt to Total Capital	42.21%	43.25%	45.32%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	57.34%	56.30%	54.09%
Debt to EBITDA	5.59	3.90	1.59
Net Debt to EBITDA	0.55	1.13	0.82
Long-Term Debt to EBITDA	5.53	3.86	1.57
Debt to NOPAT	13.40	7.55	2.27
Net Debt to NOPAT	1.33	2.18	1.17
Long-Term Debt to NOPAT	13.26	7.47	2.25
Altman Z-Score	1.98	2.41	4.05
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	10.67	10.92	9.48
Quick Ratio	9.29	9.04	6.70
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	144	173	492
Operating Cash Flow to CapEx	12,728.47%	47,341.87%	39,280.62%
Free Cash Flow to Firm to Interest Expense	2.42	2.99	7.83
Operating Cash Flow to Interest Expense	2.40	3.06	4.07
Operating Cash Flow Less CapEx to Interest Expense	2.38	3.06	4.06
Efficiency Ratios	-	-	-
Asset Turnover	0.24	0.27	0.43
Accounts Receivable Turnover	15.13	10.52	16.19
Inventory Turnover	1.52	1.16	1.52
Fixed Asset Turnover	356.38	466.70	790.87
Accounts Payable Turnover	14.90	16.61	11.17
Days Sales Outstanding (DSO)	24.12	34.70	22.54
Days Inventory Outstanding (DIO)	239.48	314.05	239.90
Days Payable Outstanding (DPO)	24.49	21.98	32.67
Cash Conversion Cycle (CCC)	239.11	326.78	229.77
Capital & Investment Metrics	-	-	-
Invested Capital	939	1,034	1,121
Invested Capital Turnover	0.43	0.43	0.58
Increase / (Decrease) in Invested Capital	-95	-87	-200
Enterprise Value (EV)	1,211	1,852	3,722
Market Capitalization	1,147	1,663	3,382
Book Value per Share	$1.32	$1.29	$1.20
Tangible Book Value per Share	($0.29)	($0.41)	($0.59)
Total Capital	1,525	1,501	1,444
Total Debt	650	656	663
Total Long-Term Debt	644	649	654
Net Debt	64	189	340
Capital Expenditures (CapEx)	1.12	0.38	0.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	46	97	153
Debt-free Net Working Capital (DFNWC)	632	564	476
Net Working Capital (NWC)	625	557	467
Net Nonoperating Expense (NNE)	29	25	47
Net Nonoperating Obligations (NNO)	64	189	340
Total Depreciation and Amortization (D&A)	55	52	51
Debt-free, Cash-free Net Working Capital to Revenue	10.85%	21.25%	21.69%
Debt-free Net Working Capital to Revenue	149.48%	123.02%	67.53%
Net Working Capital to Revenue	147.88%	121.55%	66.33%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.03	$0.09	$0.38
Adjusted Weighted Average Basic Shares Outstanding	661.98M	654.59M	649.09M
Adjusted Diluted Earnings per Share	$0.03	$0.09	$0.35
Adjusted Weighted Average Diluted Shares Outstanding	665.40M	677.58M	691.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	664.62M	660.76M	651.90M
Normalized Net Operating Profit after Tax (NOPAT)	49	87	291
Normalized NOPAT Margin	11.49%	18.96%	41.37%
Pre Tax Income Margin	6.37%	16.74%	43.34%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	1.03	2.00	5.82
NOPAT to Interest Expense	0.81	1.50	4.64
EBIT Less CapEx to Interest Expense	1.01	1.99	5.81
NOPAT Less CapEx to Interest Expense	0.80	1.49	4.63
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.95%	-9.82%	-3.62%	-4.85%	-13.08%	-14.54%	-29.98%	-48.20%	-38.89%	-21.49%	9.18%
EBITDA Growth	-31.36%	-70.75%	-13.65%	-4.43%	-32.39%	-38.04%	-50.85%	-76.48%	-59.80%	-44.56%	0.83%
EBIT Growth	-53.65%	-108.55%	-19.85%	-11.81%	-47.86%	-49.52%	-58.62%	-84.71%	-66.92%	-49.00%	-0.45%
NOPAT Growth	-69.47%	-84.81%	-26.06%	-15.63%	-50.34%	-63.46%	-59.85%	-84.81%	-65.80%	-51.39%	3.50%
Net Income Growth	-94.00%	-162.41%	-27.34%	-6.12%	-63.05%	-58.07%	-66.48%	-92.98%	-66.17%	-51.48%	7.37%
EPS Growth	-100.00%	-150.00%	-33.33%	0.00%	-66.67%	-50.00%	-66.67%	-92.31%	-66.67%	-55.56%	12.50%
Operating Cash Flow Growth	-106.67%	1.27%	-37.35%	-39.84%	-9.11%	-33.30%	-0.64%	-51.86%	-33.18%	5.47%	-2.92%
Free Cash Flow Firm Growth	-80.76%	-3.02%	-70.48%	-62.38%	402.26%	-57.85%	1,074.33%	121.47%	105.01%	0.00%	102.22%
Invested Capital Growth	-5.59%	-9.23%	-7.04%	-8.14%	-23.03%	-7.72%	-21.80%	-18.88%	-2.48%	-15.16%	3.27%
Revenue Q/Q Growth	-3.74%	-15.40%	14.56%	5.09%	-11.47%	-9.58%	13.10%	-4.00%	-12.95%	-25.92%	-16.33%
EBITDA Q/Q Growth	96.08%	-73.07%	43.64%	-9.49%	-16.44%	-20.51%	58.97%	-35.97%	-23.42%	-36.94%	-23.92%
EBIT Q/Q Growth	487.72%	-107.79%	79.01%	-14.23%	-28.51%	-26.99%	96.97%	-49.28%	-30.79%	-40.15%	-27.24%
NOPAT Q/Q Growth	109.89%	-89.88%	71.99%	-16.41%	4.44%	-50.76%	96.24%	-50.80%	-23.15%	-45.88%	-25.78%
Net Income Q/Q Growth	105.28%	-159.47%	156.05%	-25.39%	-45.07%	-30.76%	230.83%	-70.64%	-37.67%	-44.65%	-30.73%
EPS Q/Q Growth	100.00%	-150.00%	100.00%	0.00%	-50.00%	-33.33%	200.00%	-66.67%	-25.00%	-55.56%	-30.77%
Operating Cash Flow Q/Q Growth	-105.87%	48.41%	106.02%	-62.84%	-10.87%	-8.19%	97.83%	-43.86%	-34.59%	36.77%	-4.15%
Free Cash Flow Firm Q/Q Growth	-37.94%	1.34%	-5.23%	-67.72%	212.80%	-69.15%	20.78%	331.00%	-73.75%	759.45%	102.21%
Invested Capital Q/Q Growth	0.82%	-5.42%	-1.57%	0.58%	-3.06%	-3.14%	-2.73%	-15.72%	16.22%	-17.92%	0.90%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.45%	66.28%	68.64%	69.69%	72.13%	68.73%	67.62%	70.94%	71.02%	70.45%	73.58%
EBITDA Margin	23.18%	11.38%	35.75%	28.52%	33.11%	35.08%	39.90%	28.39%	42.57%	48.39%	56.85%
Operating Margin	8.74%	3.02%	23.51%	15.66%	19.83%	15.36%	29.73%	17.17%	31.25%	36.00%	50.26%
EBIT Margin	8.92%	-2.22%	24.07%	15.41%	18.88%	23.38%	28.95%	16.62%	31.47%	39.58%	48.99%
Profit (Net Income) Margin	0.48%	-8.74%	12.43%	5.56%	7.83%	12.62%	16.48%	5.64%	18.42%	25.73%	34.44%
Tax Burden Percent	52.78%	81.50%	75.26%	75.26%	74.70%	81.75%	77.56%	77.40%	82.99%	81.62%	80.01%
Interest Burden Percent	10.18%	483.74%	68.59%	47.95%	55.54%	66.05%	73.41%	43.80%	70.55%	79.66%	87.85%
Effective Tax Rate	47.22%	0.00%	24.74%	24.74%	25.30%	18.25%	22.44%	22.60%	17.01%	18.38%	19.99%
Return on Invested Capital (ROIC)	1.99%	0.91%	7.45%	4.90%	5.70%	5.34%	9.05%	5.75%	12.42%	16.94%	22.14%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.73%	-7.71%	3.76%	1.86%	3.55%	5.37%	7.13%	4.00%	11.05%	16.11%	20.78%
Return on Net Nonoperating Assets (RNNOA)	-0.22%	-1.14%	0.74%	0.47%	1.37%	1.75%	3.82%	2.55%	9.84%	14.03%	25.88%
Return on Equity (ROE)	1.78%	-0.23%	8.19%	5.37%	7.07%	7.09%	12.87%	8.30%	22.26%	30.97%	48.02%
Cash Return on Invested Capital (CROIC)	9.78%	14.60%	13.37%	15.13%	32.29%	16.10%	33.61%	33.38%	20.27%	40.27%	0.00%
Operating Return on Assets (OROA)	2.13%	-0.53%	5.96%	3.88%	4.81%	6.23%	8.04%	5.25%	12.12%	17.11%	22.73%
Return on Assets (ROA)	0.11%	-2.10%	3.08%	1.40%	2.00%	3.37%	4.58%	1.78%	7.10%	11.12%	15.98%
Return on Common Equity (ROCE)	1.78%	-0.23%	8.19%	5.37%	7.07%	7.09%	12.87%	8.30%	22.26%	30.97%	48.02%
Return on Equity Simple (ROE_SIMPLE)	1.39%	0.00%	4.82%	5.56%	5.65%	0.00%	9.65%	14.86%	25.18%	0.00%	37.60%
Net Operating Profit after Tax (NOPAT)	4.47	2.13	21	12	15	14	28	15	30	38	71
NOPAT Margin	4.61%	2.12%	17.69%	11.79%	14.82%	12.56%	23.06%	13.29%	25.94%	29.38%	40.22%
Net Nonoperating Expense Percent (NNEP)	3.73%	8.61%	3.68%	3.04%	2.15%	-0.03%	1.91%	1.75%	1.38%	0.84%	1.37%
Return On Investment Capital (ROIC_SIMPLE)	0.29%	0.14%	-	-	-	0.94%	-	-	-	2.66%	-
Cost of Revenue to Revenue	30.55%	33.72%	31.36%	30.31%	27.87%	31.27%	32.38%	29.06%	28.98%	29.55%	26.42%
SG&A Expenses to Revenue	49.48%	52.48%	36.07%	43.70%	40.88%	44.01%	29.49%	44.32%	30.69%	26.50%	17.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	60.71%	63.26%	45.13%	54.03%	52.30%	53.36%	37.89%	53.77%	39.76%	34.45%	23.31%
Earnings before Interest and Taxes (EBIT)	8.65	-2.23	29	16	19	26	36	18	36	52	86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	11	43	30	33	39	49	31	48	63	100
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.96	1.31	1.77	1.18	1.48	1.97	1.52	2.98	3.45	4.33	8.33
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.01	2.71	3.59	2.33	2.86	3.63	2.67	4.59	4.41	4.80	8.38
Price to Earnings (P/E)	68.95	58.75	36.67	21.24	26.23	27.00	15.74	20.03	13.71	13.86	22.16
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.45%	1.70%	2.73%	4.71%	3.81%	3.70%	6.35%	4.99%	7.30%	7.22%	4.51%
Enterprise Value to Invested Capital (EV/IC)	0.96	1.29	1.68	1.15	1.41	1.79	1.41	2.47	2.36	3.32	4.84
Enterprise Value to Revenue (EV/Rev)	2.17	2.87	3.85	2.66	3.19	4.04	3.15	5.12	4.87	5.29	8.93
Enterprise Value to EBITDA (EV/EBITDA)	8.59	10.40	11.58	7.72	9.30	11.03	7.83	11.17	8.94	8.95	14.17
Enterprise Value to EBIT (EV/EBIT)	17.85	19.82	18.65	12.06	14.34	15.99	10.63	14.12	10.50	10.19	15.94
Enterprise Value to NOPAT (EV/NOPAT)	23.27	24.95	26.67	16.63	19.61	21.32	13.52	17.67	13.12	12.77	19.92
Enterprise Value to Operating Cash Flow (EV/OCF)	9.46	8.47	11.71	7.17	8.18	10.43	7.45	13.41	13.28	14.58	26.29
Enterprise Value to Free Cash Flow (EV/FCFF)	9.58	8.41	12.11	7.31	3.80	10.68	3.68	6.63	11.49	7.57	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.74	0.74	0.74	0.76	0.76	0.78	0.78	0.81	0.82	0.85	0.89
Long-Term Debt to Equity	0.73	0.74	0.73	0.75	0.76	0.77	0.77	0.80	0.81	0.84	0.88
Financial Leverage	0.12	0.15	0.20	0.25	0.39	0.33	0.54	0.64	0.89	0.87	1.25
Leverage Ratio	2.03	2.04	2.04	2.07	2.09	2.11	2.17	2.24	2.35	2.50	2.67
Compound Leverage Factor	0.21	9.87	1.40	0.99	1.16	1.40	1.59	0.98	1.66	1.99	2.34
Debt to Total Capital	42.50%	42.66%	42.56%	43.07%	43.34%	43.70%	43.88%	44.60%	44.99%	45.91%	47.10%
Short-Term Debt to Total Capital	0.44%	0.44%	0.44%	0.45%	0.45%	0.45%	0.45%	0.46%	0.46%	0.58%	0.48%
Long-Term Debt to Total Capital	42.06%	42.21%	42.12%	42.62%	42.89%	43.25%	43.43%	44.14%	44.53%	45.32%	46.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	57.50%	57.34%	57.44%	56.93%	56.66%	56.30%	56.12%	55.40%	55.01%	54.09%	52.90%
Debt to EBITDA	6.11	5.59	4.52	4.33	4.30	3.90	3.42	2.71	1.92	1.59	1.42
Net Debt to EBITDA	0.64	0.55	0.78	0.96	0.97	1.13	1.18	1.15	0.84	0.82	0.88
Long-Term Debt to EBITDA	6.05	5.53	4.47	4.28	4.25	3.86	3.39	2.68	1.90	1.57	1.40
Debt to NOPAT	16.56	13.40	10.42	9.33	9.07	7.55	5.91	4.29	2.82	2.27	2.00
Net Debt to NOPAT	1.74	1.33	1.81	2.07	2.04	2.18	2.04	1.82	1.24	1.17	1.24
Long-Term Debt to NOPAT	16.39	13.26	10.31	9.23	8.97	7.47	5.84	4.24	2.79	2.25	1.98
Altman Z-Score	1.69	1.86	2.22	1.79	1.96	2.23	1.98	2.71	3.00	3.44	5.15
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	10.74	10.67	11.84	9.27	10.71	10.92	10.69	9.32	9.68	9.48	5.61
Quick Ratio	9.22	9.29	10.14	7.67	8.93	9.04	8.57	7.00	7.12	6.70	3.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	61	98	96	102	315	101	326	270	63	239	28
Operating Cash Flow to CapEx	-6,077.08%	11,441.94%	25,542.75%	15,038.89%	9,691.13%	36,055.15%	48,117.12%	128,561.90%	44,942.99%	13,366.73%	215,016.00%
Free Cash Flow to Firm to Interest Expense	4.41	6.56	6.17	6.96	21.70	6.86	22.20	18.40	4.50	17.95	2.65
Operating Cash Flow to Interest Expense	-0.21	3.34	2.14	1.11	3.01	3.34	3.64	1.84	3.46	5.53	5.12
Operating Cash Flow Less CapEx to Interest Expense	-0.22	3.31	2.14	1.11	2.98	3.33	3.63	1.84	3.45	5.49	5.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.24	0.24	0.25	0.25	0.25	0.27	0.28	0.32	0.39	0.43	0.46
Accounts Receivable Turnover	16.95	15.13	10.00	10.40	12.43	10.52	6.58	8.06	11.04	16.19	9.70
Inventory Turnover	1.52	1.52	1.32	1.17	1.18	1.16	1.09	1.12	1.38	1.52	1.64
Fixed Asset Turnover	309.48	356.38	400.23	406.23	391.19	466.70	618.67	661.93	715.59	790.87	1,042.33
Accounts Payable Turnover	6.37	14.90	10.63	7.31	6.25	16.61	5.41	5.44	5.86	11.17	6.68
Days Sales Outstanding (DSO)	21.53	24.12	36.51	35.10	29.35	34.70	55.50	45.31	33.05	22.54	37.62
Days Inventory Outstanding (DIO)	239.53	239.48	276.03	311.39	308.11	314.05	336.13	327.12	263.63	239.90	222.97
Days Payable Outstanding (DPO)	57.26	24.49	34.32	49.96	58.43	21.98	67.51	67.11	62.26	32.67	54.62
Cash Conversion Cycle (CCC)	203.79	239.11	278.22	296.54	279.04	326.78	324.13	305.32	234.42	229.77	205.97
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	947	939	993	1,009	1,003	1,034	1,068	1,098	1,303	1,121	1,366
Invested Capital Turnover	0.43	0.43	0.42	0.42	0.38	0.43	0.39	0.43	0.48	0.58	0.55
Increase / (Decrease) in Invested Capital	-56	-95	-75	-89	-300	-87	-298	-256	-33	-200	43
Enterprise Value (EV)	912	1,211	1,669	1,164	1,416	1,852	1,504	2,714	3,074	3,722	6,612
Market Capitalization	844	1,147	1,556	1,019	1,269	1,663	1,277	2,434	2,784	3,382	6,199
Book Value per Share	$1.32	$1.32	$1.33	$1.30	$1.30	$1.29	$1.28	$1.25	$1.24	$1.20	$1.15
Tangible Book Value per Share	($0.27)	($0.29)	($0.30)	($0.35)	($0.38)	($0.41)	($0.44)	($0.49)	($0.53)	($0.59)	($0.66)
Total Capital	1,527	1,525	1,532	1,516	1,510	1,501	1,497	1,476	1,466	1,444	1,406
Total Debt	649	650	652	653	654	656	657	658	660	663	662
Total Long-Term Debt	642	644	645	646	648	649	650	652	653	654	656
Net Debt	68	64	113	145	147	189	228	280	290	340	413
Capital Expenditures (CapEx)	0.05	0.43	0.13	0.11	0.45	0.14	0.11	0.02	0.11	0.55	0.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)	64	46	81	83	79	97	122	138	143	153	166
Debt-free Net Working Capital (DFNWC)	645	632	620	591	587	564	551	516	512	476	415
Net Working Capital (NWC)	638	625	613	584	580	557	544	509	505	467	409
Net Nonoperating Expense (NNE)	4.01	11	6.27	6.47	6.91	-0.07	8.13	8.36	8.55	4.77	10
Net Nonoperating Obligations (NNO)	68	64	113	145	147	189	228	280	496	340	622
Total Depreciation and Amortization (D&A)	14	14	14	14	14	13	14	13	13	12	14
Debt-free, Cash-free Net Working Capital to Revenue	15.25%	10.85%	18.70%	18.87%	17.82%	21.25%	25.48%	25.97%	22.59%	21.69%	22.44%
Debt-free Net Working Capital to Revenue	153.31%	149.48%	142.95%	134.80%	132.27%	123.02%	115.48%	97.34%	81.04%	67.53%	56.14%
Net Working Capital to Revenue	151.71%	147.88%	141.39%	133.26%	130.75%	121.55%	114.07%	96.07%	79.97%	66.33%	55.22%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.01)	$0.02	$0.01	$0.01	$0.02	$0.03	$0.01	$0.03	$0.05	$0.09
Adjusted Weighted Average Basic Shares Outstanding	664.69M	661.98M	662.25M	661.73M	660.82M	654.59M	654.70M	654.35M	651.73M	649.09M	649.10M
Adjusted Diluted Earnings per Share	$0.00	($0.01)	$0.02	$0.01	$0.01	$0.02	$0.03	$0.01	$0.03	$0.04	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	666.46M	665.40M	666.15M	663.55M	663.57M	677.58M	678.76M	680.35M	683.49M	691.01M	691.26M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	665.92M	664.62M	662.92M	661.98M	661.76M	660.76M	654.73M	654.70M	654.28M	651.90M	649.18M
Normalized Net Operating Profit after Tax (NOPAT)	4.47	2.13	21	12	15	14	28	15	30	38	71
Normalized NOPAT Margin	4.61%	2.12%	17.69%	11.79%	14.82%	12.56%	23.06%	13.29%	25.94%	29.38%	40.22%
Pre Tax Income Margin	0.91%	-10.72%	16.51%	7.39%	10.48%	15.44%	21.25%	7.28%	22.20%	31.52%	43.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.63	-0.15	1.84	1.10	1.29	1.78	2.43	1.24	2.57	3.89	8.23
NOPAT to Interest Expense	0.33	0.14	1.35	0.84	1.01	0.96	1.94	0.99	2.12	2.89	6.76
EBIT Less CapEx to Interest Expense	0.63	-0.18	1.83	1.09	1.26	1.77	2.43	1.24	2.56	3.85	8.23
NOPAT Less CapEx to Interest Expense	0.32	0.11	1.34	0.83	0.98	0.95	1.93	0.99	2.11	2.85	6.76
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Olaplex's Financials

When does Olaplex's financial year end?

According to the most recent income statement we have on file, Olaplex's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Olaplex's net income changed over the last 2 years?

Olaplex's net income appears to be on a downward trend, with a most recent value of $19.52 million in 2024, falling from $244.07 million in 2022. The previous period was $61.59 million in 2023. See where experts think Olaplex is headed by visiting Olaplex's forecast page.

What is Olaplex's operating income?

Olaplex's total operating income in 2024 was $66.94 million, based on the following breakdown:

Total Gross Profit: $292.29 million
Total Operating Expenses: $225.35 million

How has Olaplex revenue changed over the last 2 years?

Over the last 2 years, Olaplex's total revenue changed from $704.27 million in 2022 to $422.67 million in 2024, a change of -40.0%.

How much debt does Olaplex have?

Olaplex's total liabilities were at $893.32 million at the end of 2024, a 0.2% decrease from 2023, and a 2.6% decrease since 2022.

How much cash does Olaplex have?

In the past 2 years, Olaplex's cash and equivalents has ranged from $322.81 million in 2022 to $585.97 million in 2024, and is currently $585.97 million as of their latest financial filing in 2024.

How has Olaplex's book value per share changed over the last 2 years?

Over the last 2 years, Olaplex's book value per share changed from 1.20 in 2022 to 1.32 in 2024, a change of 9.6%.

Related Companies

This page (NASDAQ:OLPX) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Olaplex (OLPX) Financials

Frequently Asked Questions About Olaplex's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Olaplex (OLPX) Financials

Annual Income Statements for Olaplex

Quarterly Income Statements for Olaplex

Annual Cash Flow Statements for Olaplex

Quarterly Cash Flow Statements for Olaplex

Annual Balance Sheets for Olaplex

Quarterly Balance Sheets for Olaplex

Annual Metrics And Ratios for Olaplex

Quarterly Metrics And Ratios for Olaplex

Frequently Asked Questions About Olaplex's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools